RIGL
Price
$0.98
Change
+$0.01 (+1.03%)
Updated
May 16, 6:59 PM EST
74 days until earnings call
SNDX
Price
$20.94
Change
-$1.00 (-4.56%)
Updated
May 16, 6:59 PM EST
80 days until earnings call
Ad is loading...

RIGL vs SNDX

Header iconRIGL vs SNDX Comparison
Open Charts RIGL vs SNDXBanner chart's image
Rigel Pharmaceuticals
Price$0.98
Change+$0.01 (+1.03%)
Volume$209.73K
CapitalizationN/A
Syndax Pharmaceuticals
Price$20.94
Change-$1.00 (-4.56%)
Volume$710.42K
CapitalizationN/A
View a ticker or compare two or three
RIGL vs SNDX Comparison Chart

Loading...

RIGLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNDXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
RIGL vs. SNDX commentary
May 17, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RIGL is a Hold and SNDX is a Sell.

COMPARISON
Comparison
May 17, 2024
Stock price -- (RIGL: $0.98 vs. SNDX: $20.92)
Brand notoriety: RIGL and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RIGL: 24% vs. SNDX: 108%
Market capitalization -- RIGL: $172.34M vs. SNDX: $1.78B
RIGL [@Biotechnology] is valued at $172.34M. SNDX’s [@Biotechnology] market capitalization is $1.78B. The market cap for tickers in the [@Biotechnology] industry ranges from $592.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RIGL’s FA Score shows that 0 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • RIGL’s FA Score: 0 green, 5 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, SNDX is a better buy in the long-term than RIGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RIGL’s TA Score shows that 4 TA indicator(s) are bullish while SNDX’s TA Score has 1 bullish TA indicator(s).

  • RIGL’s TA Score: 4 bullish, 4 bearish.
  • SNDX’s TA Score: 1 bullish, 8 bearish.
According to our system of comparison, RIGL is a better buy in the short-term than SNDX.

Price Growth

RIGL (@Biotechnology) experienced а -3.68% price change this week, while SNDX (@Biotechnology) price change was -4.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.45%. For the same industry, the average monthly price growth was +4.26%, and the average quarterly price growth was +63.16%.

Reported Earning Dates

RIGL is expected to report earnings on Jul 30, 2024.

SNDX is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Biotechnology (+2.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for RIGL with price predictions.
OPEN
A.I.dvisor published
a Summary for SNDX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SNDX($1.78B) has a higher market cap than RIGL($172M). SNDX YTD gains are higher at: 1.527 vs. RIGL (-33.145).
RIGLSNDXRIGL / SNDX
Capitalization172M1.78B10%
EBITDAN/AN/A-
Gain YTD-33.1451.527-2,170%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
RIGL vs SNDX: Fundamental Ratings
RIGL
SNDX
OUTLOOK RATING
1..100
412
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
10038
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
6448
P/E GROWTH RATING
1..100
1005
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RIGL's Valuation (85) in the Biotechnology industry is in the same range as SNDX (85). This means that RIGL’s stock grew similarly to SNDX’s over the last 12 months.

SNDX's Profit vs Risk Rating (38) in the Biotechnology industry is somewhat better than the same rating for RIGL (100). This means that SNDX’s stock grew somewhat faster than RIGL’s over the last 12 months.

SNDX's SMR Rating (96) in the Biotechnology industry is in the same range as RIGL (100). This means that SNDX’s stock grew similarly to RIGL’s over the last 12 months.

SNDX's Price Growth Rating (48) in the Biotechnology industry is in the same range as RIGL (64). This means that SNDX’s stock grew similarly to RIGL’s over the last 12 months.

SNDX's P/E Growth Rating (5) in the Biotechnology industry is significantly better than the same rating for RIGL (100). This means that SNDX’s stock grew significantly faster than RIGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RIGLSNDX
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
72%
View a ticker or compare two or three
Ad is loading...
RIGLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNDXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STMOX34.140.43
+1.28%
Sterling Capital Real Estate C
FRDPX93.820.77
+0.83%
Franklin Rising Dividends A
BRUDX16.760.13
+0.78%
MFS Blended Research Value Equity A
COSOX10.520.07
+0.67%
Columbia Overseas Core Institutional 3
SFNNX11.25N/A
N/A
Schwab Fdmtl Intl Lg Co Idx

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with AUTL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then AUTL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
+2.31%
AUTL - RIGL
38%
Loosely correlated
N/A
NTLA - RIGL
36%
Loosely correlated
+1.90%
SNDX - RIGL
34%
Loosely correlated
+1.29%
RCUS - RIGL
33%
Loosely correlated
+2.57%
PRME - RIGL
32%
Poorly correlated
+1.50%
More

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with NTLA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
+1.29%
NTLA - SNDX
48%
Loosely correlated
+1.90%
NRIX - SNDX
46%
Loosely correlated
+6.35%
RAPT - SNDX
45%
Loosely correlated
+6.12%
VCYT - SNDX
45%
Loosely correlated
+2.30%
RNA - SNDX
44%
Loosely correlated
+2.08%
More